HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma.

Abstract
Colorectal cancer is a disease that is associated with default in the balance of apoptotic regulation. In the present study apoptosis was examined in 158 colorectal adenocarcinomas using the terminal deoxynucleotidyl transferase mediated digoxigenin nick end labeling (TUNEL) method. The median apoptotic index (AI) was 0.95% (range 0-6. 68%). Eighty-two tumours exhibited AI </=0.95% and 76 tumours showed AI >0.95%. We revealed a positive correlation between apoptosis and proliferation determined as the expression of proliferating cell nuclear antigen (PCNA, p=0.002). The frequency of apoptosis increased from Dukes' stage A, B, C to D (p=0.01). No correlations were found between apoptosis and the patients' sex, age, tumour location, growth pattern, differentiation, prognosis, bcl-2, p53 or K-ras. Our findings suggest that we should further investigate the relationship between apoptosis and cellular proliferative activity in colorectal cancer to evaluate whether this might provide additional information in the selection of patients for effective adjuvant therapy.
AuthorsS Evertsson, Z Bartik, H Zhang, A Jansson, X F Sun
JournalInternational journal of oncology (Int J Oncol) Vol. 15 Issue 1 Pg. 53-8 (Jul 1999) ISSN: 1019-6439 [Print] Greece
PMID10375593 (Publication Type: Journal Article)
Chemical References
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Proliferating Cell Nuclear Antigen
Topics
  • Adenocarcinoma (chemistry, genetics, mortality, pathology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Neoplasm (analysis)
  • Apoptosis
  • Biomarkers, Tumor (analysis)
  • Cell Division
  • Colorectal Neoplasms (chemistry, genetics, mortality, pathology)
  • Female
  • Genes, bcl-2
  • Genes, p53
  • Genes, ras
  • Humans
  • In Situ Nick-End Labeling
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Proliferating Cell Nuclear Antigen (analysis)
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: